WatersWAT +2.52%92 OCF Margin % is -0.24% as of Mar. 2026. GuruFocus rates WAT with a GF Score™ of 92/100 and a GF Value™ of $415.96 (Fairly Valued). The stock has 7 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Waters ranks better than 58.82% on this metric.
The historical rank and industry rank for Waters's OCF Margin % or its related term are showing as below:
WAT'
s OCF Margin % Range Over the Past 10 Years
Min: 20.39 Med: 26.24 Max: 33.42
Current: 10.33
During the past 13 years, the highest OCF Margin % of Waters was 33.42%. The lowest was 20.39%. And the median was 26.24%.
WAT's OCF Margin % is ranked better than 58.82% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: 4.755
vs WAT: 10.33
Waters OCF Margin % Related Terms
Waters OCF Margin % Historical Data
* Premium members only.
The historical data trend for Waters's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Waters's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Waters OCF Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Waters's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Waters's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Waters (WAT) has a OCF Margin % of -0.24% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Waters and its competitors. Over the past decade, Waters' OCF Margin % has ranged from 20.39 to 33.42. According to the industry distribution chart, Waters ranks #84 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 41.2%.
Is Waters' OCF Margin % too high?
Waters' current OCF Margin % is -0.24%. Over the past 10 years, this metric has ranged from a low of 20.39 to a high of 33.42. Based on the distribution chart, Waters ranks #84 out of 204 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Waters has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Waters' OCF Margin % compare to A and NTRA?
According to the Medical Diagnostics & Research industry distribution chart, Waters ranks #84 out of 204 companies for OCF Margin %. This puts Waters in the upper half of its industry. The industry median OCF Margin % is 4.76. Historically, Waters' own OCF Margin % has ranged from 20.39 to 33.42 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Diagnostics & Research company?
The median OCF Margin % among Medical Diagnostics & Research companies is 4.76, based on 204 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Waters and its competitors. For the Medical Diagnostics & Research industry, the median OCF Margin % is 4.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Waters's current OCF Margin % is -0.24%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Waters stock overvalued right now?
Based on GuruFocus' analysis, Waters (WAT) is currently considered Fairly Valued. The stock's GF Value™ is $415.96, compared to a current price of $378.49 — trading 9% below its estimated fair value. The current OCF Margin % is -0.24%. Waters' overall GF Score™ is 92/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Waters (WAT), the current OCF Margin % is -0.24% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Waters (WAT) Overvalued in 2026?
Based on GuruFocus' analysis, Waters stock appears to be undervalued.
The current stock price of $378.49 is trading 9% below its estimated GF Value™ of $415.96.
GuruFocus considers Waters to be Fairly Valued.
Key valuation signals for WAT:
OCF Margin %: -0.24%
GF Value™: $415.96 vs. price of $378.49 (9% below fair value)
No single metric tells the full story. See the WAT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with BD's life science and diagnostics business, which increased its concentration in diagnostics (versus none now) and discovery-related life science tools.
92GF Score
Get the complete analysis for WAT
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAT has been successfully added to your 
